SARISSA BIOMEDICAL LIMITED - SOUTHAMPTON
Company Profile | Company Filings |
Overview
SARISSA BIOMEDICAL LIMITED is a Private Limited Company from SOUTHAMPTON and has the status: Liquidation.
SARISSA BIOMEDICAL LIMITED was incorporated 21 years ago on 04/11/2002 and has the registered number: 04581254. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2021.
SARISSA BIOMEDICAL LIMITED was incorporated 21 years ago on 04/11/2002 and has the registered number: 04581254. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2021.
SARISSA BIOMEDICAL LIMITED - SOUTHAMPTON
This company is listed in the following categories:
21100 - Manufacture of basic pharmaceutical products
21100 - Manufacture of basic pharmaceutical products
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2019 | 30/09/2021 |
Registered Office
C/O JAMES COWPER KRESTON THE WHITE BUILDING
SOUTHAMPTON
SO15 2NP
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
04/11/2020 | 18/11/2021 |
Map
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MERCIA FUND MANAGEMENT (NOMINEES) LIMITED | Corporate Director | 2016-02-18 | CURRENT | ||
MICHAEL ZELIN | Nov 1960 | American | Director | 2020-11-04 | CURRENT |
GEORGE THOMAS ZAJICEK | Jun 1949 | British | Director | 2017-08-22 | CURRENT |
JOHN CLARKSON | Mar 1957 | British | Director | 2019-06-01 | CURRENT |
NICHOLAS EGERTON DALE | Mar 1960 | British | Director | 2002-11-04 | CURRENT |
NICHOLAS EGERTON DALE | Mar 1960 | British | Secretary | 2002-11-04 | CURRENT |
WARWICK VENTURES LIMITED | Corporate Director | 2014-08-12 UNTIL 2017-04-10 | RESIGNED | ||
DR EDERYN WILLIAMS | Sep 1946 | British | Director | 2009-08-26 UNTIL 2011-09-30 | RESIGNED |
DR BRIAN MICHAEL STAMMERS | Jun 1947 | British | Director | 2004-05-19 UNTIL 2007-02-16 | RESIGNED |
MR WILLIAM PENN MOFFITT | Nov 1946 | American | Director | 2017-11-14 UNTIL 2021-01-06 | RESIGNED |
DR EVERARD JOSEPH PHILIP MASCARENHAS | Feb 1960 | British | Director | 2014-08-12 UNTIL 2019-03-28 | RESIGNED |
MR GARY ALLAN GLASS | Dec 1958 | British | Director | 2015-12-22 UNTIL 2018-11-09 | RESIGNED |
PROFESSOR BRUNO GERALD FRENGUELLI | Aug 1967 | British | Director | 2010-04-20 UNTIL 2020-09-18 | RESIGNED |
MR QUENTIN MARK COMPTON-BISHOP | Jul 1956 | British | Director | 2011-10-27 UNTIL 2014-08-12 | RESIGNED |
MR QUENTIN MARK COMPTON-BISHOP | Jul 1958 | British | Director | 2017-04-26 UNTIL 2019-09-18 | RESIGNED |
ENRIQUE LLAUDET CARLES | Mar 1975 | Spanish | Director | 2002-11-04 UNTIL 2006-08-31 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Mercia Fund Management Limited | 2018-11-01 | Henley-In-Arden |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
|
The Mercia Fund 1 | 2016-11-04 - 2018-11-01 | Henley-In-Arden |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Sarissa Biomedical Limited - Accounts to registrar (filleted) - small 18.2 | 2020-06-23 | 31-12-2019 | £311,945 Cash £341,158 equity |
Sarissa Biomedical Limited - Accounts to registrar (filleted) - small 18.2 | 2019-06-18 | 31-12-2018 | £121,331 Cash £29,830 equity |
Sarissa Biomedical Limited - Accounts to registrar (filleted) - small 18.1 | 2018-09-29 | 31-12-2017 | £694,008 Cash £427,168 equity |
Sarissa Biomedical Limited - Accounts to registrar - small 17.2 | 2017-09-30 | 31-12-2016 | £291,991 Cash £258,143 equity |
Sarissa Biomedical Limited - Abbreviated accounts 16.1 | 2016-09-29 | 31-12-2015 | £223,829 Cash £208,708 equity |
Sarissa Biomedical Limited - Limited company - abbreviated - 11.6 | 2015-09-29 | 31-12-2014 | £111,238 Cash £173,438 equity |
Sarissa Biomedical Limited - Limited company - abbreviated - 11.0.0 | 2014-09-17 | 31-12-2013 | £23,016 Cash £89,189 equity |